Unaudited Condensed Consolidated Statement of Cash Flows Statement (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Cash flows from operating activities:
Net income	$ 120,552	$ 127,751
Adjustments to reconcile net income to net cash provided by operating activities:
Gains on early extinguishment of debt, net	(468)	0
Depreciation and amortization	91,945	89,349
Amortization of intangible assets	16,619	17,950
Amortization of cemetery property	32,036	31,528
Amortization of loan costs	3,997	3,635
Provision for doubtful accounts	5,238	6,801
Provision for deferred income taxes	55,784	57,428
Losses (gains) on divestitures and impairment charges, net	5,533	(883)
Share-based compensation	8,887	8,217
Excess tax benefits from share based awards	(6,083)	0
Change in assets and liabilities, net of effects from acquisitions and divestitures:
Decrease in receivables	14,487	1,066
Increase (decrease) in other assets	(14,636)	(6,331)
Decrease in payables and other liabilities	24,767	6,623
Effect of preneed funeral production and maturities:
Decrease in preneed funeral receivables, net and trust investments	33,066	34,134
Decrease in deferred preneed funeral revenue	(10,202)	(30,325)
Decrease in deferred preneed funeral receipts held in trust	(34,026)	(18,185)
Effect of cemetery production and deliveries:
Increase in preneed cemetery receivables, net and trust investments	(49,500)	(72,012)
Increase in deferred preneed cemetery revenue	36,183	27,502
(Decrease) increase in deferred preneed cemetery receipts held in trust	(8,051)	(480)
Other	306	(3,481)
Net cash provided by operating activities	326,434	280,287
Cash flows from investing activities:
Capital expenditures	(79,586)	(80,973)
Acquisitions	(8,543)	(19,281)
Proceeds from divestitures and sales of property and equipment, net	10,013	8,933
Other	341	(3,816)
Net cash used in investing activities	(77,775)	(95,137)
Cash flows from financing activities:
Proceeds from issuance of long-term debt	0	17,907
Payments of debt	(91,794)	(988)
Principal payments on capital leases	(19,585)	(19,303)
Proceeds from exercise of stock options	4,954	17,347
Excess tax benefits from share based awards	6,083	0
Purchase of Company common stock	(1,708)	(144,607)
Payments of dividends	(42,371)	(34,844)
Purchase of noncontrolling interest	(8,333)	0
Bank overdrafts and other	(5,479)	868
Net cash used in financing activities	(158,233)	(163,620)
Effect of foreign currency on cash and cash equivalents	(542)	1,448
Net decrease in cash and cash equivalents	89,884	22,978
Cash and cash equivalents at beginning of period	92,708	128,569
Cash and cash equivalents at end of period	$ 182,592	$ 151,547